Cargando…

Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency

Good Clinical Practice (GCP) is an international standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials. The goal of GCP is to ensure the protection of the rights, integrity, and confidentiality of clinical trial participants and to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arango, Jaime, Chuck, Tina, Ellenberg, Susan S., Foltz, Bridget, Gorman, Colleen, Hinrichs, Heidi, McHale, Susan, Merchant, Kunal, Seltzer, Jonathan, Shapley, Stephanie, Wild, Gretchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Regulatory Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923807/ https://www.ncbi.nlm.nih.gov/pubmed/27390628 http://dx.doi.org/10.1177/2168479016635220

Ejemplares similares

4500 Providing a System for Practical Monitoring Training for Clinical Trials within Academic Institutions
por: Chandramohan, Advaita, et al.
Publicado: (2020)

81007 Training Biomedical Engineers in Regulatory Science: Critical Role of Experts from Industry and FDA
por: Lottes, Aaron E., et al.
Publicado: (2021)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022)

Investigating the effects of differently produced synthetic amorphous silica (E 551) on the integrity and functionality of the human intestinal barrier using an advanced in vitro co-culture model
por: Hempt, Claudia, et al.
Publicado: (2020)

3080 Ensuring Quality in Investigator-Initiated Clinical Trials through Monitoring Concepts Training
por: Spinrad, Amelia, et al.
Publicado: (2019)

Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model
por: Tonnelier, Arnaud, et al.
Publicado: (2011)

Indian Regulatory Update: Jan-May 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Sensory irritation as a basis for setting occupational exposure limits
por: Brüning, Thomas, et al.
Publicado: (2014)

Indian Regulatory Update: June-August 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian regulatory update 2013
por: Suvarnapathaki, Kedar
Publicado: (2013)

Indian Regulatory Update: September-November 2013
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian Regulatory Update: January-March 2015
por: Suvarnapathaki, Kedar
Publicado: (2015)

Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science
por: Rouse, Rodney, et al.
Publicado: (2017)

Indian Regulatory Update: January-December 2017
por: Bhave, Amita
Publicado: (2018)

Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods
por: Casati, S., et al.
Publicado: (2017)

Predicting in vivo effect levels for repeat-dose systemic toxicity using chemical, biological, kinetic and study covariates
por: Truong, Lisa, et al.
Publicado: (2017)

Indian Regulatory Update: January – March 2018
por: Bhave, Amita
Publicado: (2018)

Current pesticide dietary risk assessment in light of comparable animal study NOAELs after chronic and short-termed exposure durations
por: Zarn, Jürg A., et al.
Publicado: (2017)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

Indian regulatory update April–October 2018
por: Bhave, Amita, et al.
Publicado: (2019)

A framework for the use of single-chemical transcriptomics data in predicting the hazards associated with complex mixtures of polycyclic aromatic hydrocarbons
por: Labib, Sarah, et al.
Publicado: (2016)

Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment
por: Farmahin, Reza, et al.
Publicado: (2016)

Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019
por: Gustafson, Emma, et al.
Publicado: (2020)

Indian regulatory update during the COVID-19 pandemic
por: Bhave, Amita Chandan
Publicado: (2020)

Survey of Japanese Orphan Drug Program: Factors Related to Successful Marketing Approval
por: Harada, Kenji, et al.
Publicado: (2019)

Indian Regulatory Update-2 during the COVID-19 pandemic
por: Bhave, Amita
Publicado: (2020)

Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
por: Fayyaz, Susann, et al.
Publicado: (2021)

Principles of dose-setting in toxicology studies: the importance of kinetics for ensuring human safety
por: Borgert, C. J., et al.
Publicado: (2021)

A framework for chemical safety assessment incorporating new approach methodologies within REACH
por: Ball, Nicholas, et al.
Publicado: (2022)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6441brdgs7otiaj541enaif2m3